Skip to main content
SpringerLink
Log in

The impact of nuts on diabetes and diabetes risk

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Nuts have many nutritional benefits: they are high in monounsaturated and polyunsaturated fats, fiber, vitamin, minerals, and phytonutrients. Population studies indicate that individuals who regularly consume nuts have reduced risk for cardiovascular disease and diabetes. In clinical trials, nuts appear to have a neutral effect on glucose and insulin, and a beneficial effect on lipid profile. Thus, nuts can be a healthy dietary component for individuals with diabetes or those at risk for diabetes, providing overall caloric intake is regulated to maintain a healthy body weight.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. USDA National Nutrient Database. http://www.nal.usda.gov/ fnic/foodcomp/search. Accessed May 16, 2005.

  2. Jiang R, Manson JE, Stampfer MJ, et al.: Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA 2002, 288:2554–2560. In this prospective, nationwide cohort study of over 83,000 nurses with 16 years of follow-up, women with higher nut and peanut butter consumption had reduced risk of developing type 2 diabetes.

    Article  PubMed  Google Scholar 

  3. Lovejoy JC, Most MM, Lefevre M, et al.: Effect of diets enriched in almonds on insulin action and serum lipids in adults with normal glucose tolerance or type 2 diabetes. Am J Clin Nutr 2002, 76:1000–1006.

    PubMed  CAS  Google Scholar 

  4. Lovejoy JC: The influence of dietary fat on insulin resistance. Curr Diab Rep 2002, 2:435–440.

    Google Scholar 

  5. Riccardi G, Giacco R, Rivellese AA: Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 2004, 23:447–456.

    Article  PubMed  CAS  Google Scholar 

  6. Garcia-Lorda P, Rangil IM, Salas-Salvado J: Nut consumption, body weight and insulin resistance. Eur J Clin Nutr 2003, 57(suppl 1):S8-S11.

    Article  PubMed  CAS  Google Scholar 

  7. St-Ong MP: Dietary fats, teas, dairy and nuts: potential functional foods for weight control? Am J Clin Nutr 2005, 81:7–15.

    Google Scholar 

  8. Soriguer FJ, Gonzales-Romero S, Esteva I, et al.: Does the intake of nuts and seeds alter the appearance of menarche? Acta Obstet Gynecol Scand 1995, 74:455–461.

    PubMed  CAS  Google Scholar 

  9. Fraser GE, Bennett HW, Jaceldo KB, Sabate J: Effect on body weight of a free 76 Kilojoule (320 calorie) daily supplement of almonds for six months. J Am Coll Nutr 2002, 21:275–283.

    PubMed  Google Scholar 

  10. Almario RU, Vonghavaravat V, Wong R, Kasim-Karakas SE: Effects of walnut consumption on plasma fatty acids and lipoproteins in combined hyperlipidemia. Am J Clin Nutr 2001, 74:72–79.

    PubMed  CAS  Google Scholar 

  11. Morgan WA, Clayshulte BJ: Pecans lower low-density lipoprotein cholesterol in people with normal lipid levels. J Am Diet Assoc 2000, 100:312–318.

    Article  PubMed  CAS  Google Scholar 

  12. Nutrition recommendations and principles for people with diabetes mellitus. American Diabetes Association [no authors listed]. Diabetes Care 1994, 17:519-522.

  13. 13. Ros E: Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 2003, 78(suppl):617S-625S.

    PubMed  CAS  Google Scholar 

  14. Luscombe ND, Noakes M, Clifton PM: Diets high and low in glycemic index vs. high monounsaturated fat diets: effects on glucose and lipid metabolism in NIDDM. Eur J Clin Nutr 1999, 53:473–478.

    Article  PubMed  CAS  Google Scholar 

  15. Campbell LV, Marmot PE, Dyer JA, et al..: The high-monounsaturated fat diet as a practical alternative for NIDDM. Diabetes Care 1994, 17:177–182.

    Article  PubMed  CAS  Google Scholar 

  16. Fraser GE, Sabate J, Beeson WL, Strahan TM: A possible protective effect of nut consumption on risk of coronary heart disease. Arch Intern Med 1992, 152:1416–1424.

    Article  PubMed  CAS  Google Scholar 

  17. Kushi L, Folsom AR, Prineas RJ, et al.: Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996, 334:1156–1162.

    Article  PubMed  CAS  Google Scholar 

  18. Sabate J: Nut consumption, vegetarian diets, ischemic heart disease risk, and all-cause mortality: evidence from epidemiologic studies. Am J Clin Nutr 1999, 70(snsuppl):500S-503S.

    Google Scholar 

  19. Albert CM, Gaziano JM, Willett WC, Manson JE: Nut consumption and decreased risk of sudden cardiac death in the Physicians’ Health Study. Arch Intern Med 2002, 162:1382–1387.

    Article  PubMed  Google Scholar 

  20. Hu FB, Stampfer MJ, Manson JE, et al..: Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ 1998, 317:1341–1345.

    PubMed  CAS  Google Scholar 

  21. Lavedrine F, Zmirou D, Ravel A, et al.: Blood cholesterol and walnut consumption: a cross-sectional survey in France. Prev Med 1999, 28:333–339.

    Article  PubMed  CAS  Google Scholar 

  22. Sabate J, Fraser GE, Burke K, et al.: Effects of walnuts on serum lipid levels and blood pressure in normal men. N Engl J Med 1993, 328:603-607.

    Article  PubMed  CAS  Google Scholar 

  23. Chisholm A, Mann J, Skeaff M, et al.: A diet rich in walnuts favourably influences plasma fatty acid profile in moderately hyperlipidaemic subjects. Eur J Clin Nutr 1998, 52:12–16.

    Article  PubMed  CAS  Google Scholar 

  24. Spiller GA, Jenkins DJA, Bosello O, et al..: Nuts and plasma lipids: An almond-based diet lowers LDL-C while preserving HDL-C. J Am Coll Nutr 1998, 17:285–290.

    PubMed  CAS  Google Scholar 

  25. Spiller GA, Jenkins DJA, Cragen LN, et al..: Effect of a diet high in monounsaturated fat from almonds on plasma cholesterol and lipoproteins. J Am Coll Nutr 1992, 11:126–130.

    PubMed  CAS  Google Scholar 

  26. Colquhoun DM, Humphries JA, Moores D, Somerset SM: Effects of a macadamia nut enriched diet on serum lipids and lipoproteins compared to a low fat diet. Food Aust 1996, 48:216–222.

    Google Scholar 

  27. O’Byrne DJ, Knauft DA, Shireman RB: Low-fat monounsaturated rich diets containing high-oleic peanuts improve serum lipoprotein profiles. Lipids 1997, 32:687–695.

    Article  PubMed  CAS  Google Scholar 

  28. Kris-Etherton PM, Pearson TA, Wan Y, et al..: High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations. Am J Clin Nutr 1999, 70:1009–1015.

    PubMed  CAS  Google Scholar 

  29. Abbey M, Noakes M, Belling GB, Nestel PJ: Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am J Clin Nutr 1994, 59:995–999.

    PubMed  CAS  Google Scholar 

  30. Curb JD, Wergowske G, Dobbs JC, et al.: Serum lipid effects of a high-monounsaturated fat diet based on macadamia nuts. Arch Int Med 2000, 160:1154–1158.

    Article  CAS  Google Scholar 

  31. Alper CM, Mattes RD: Peanut consumption improves indices of cardiovascular disease risk in healthy adults. J Am Coll Nutr 2003, 22:133–141.

    PubMed  Google Scholar 

  32. Tapsell LC, Gillen LJ, Patch CS, et al.: Including walnuts in a low-fat/modified-fat diet improves HDL cholesterol-to-total cholesterol ratios in patients with type 2 diabetes. ZA Diabetes Care 2004, 27:2777–2783. A randomized controlled clinical trial in diabetic patients comparing three diets (all 30% total fat): low-fat control, low-fat diet using exchange lists to modify fatty acid consumption, and low-fat diet with 30 g of walnuts supplemented per day. The walnut group had lower low-density lipoprotein cholesterol, higher HDL cholesterol, and similar hemoglobin A1c than the other groups.

    Article  Google Scholar 

  33. Garg A: High-monounsaturated fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998, 76:577S-582S.

    Google Scholar 

  34. Lopez-Ridaura R, Willett WC, Rimm EB, et al.: Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care 2004, 27:134–140. In this analysis of follow-up data from approximately 85,000 women in the Nurses’ Health Study and approximately 43,000 men in the Health Professionals’ Follow-up Study, higher intakes of dietary magnesium were associated with lower risk for developing diabetes, suggesting a possible mechanism for the protective effect of nuts, which are a high-magnesium food.

    Article  PubMed  CAS  Google Scholar 

  35. Rosolova H, Mayer O Jr, Reaven GM: Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 2000, 49:418–420.

    Article  PubMed  CAS  Google Scholar 

  36. Kao WH, Folsom AR, Nieto FJ, et al.: Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999, 159:2151–2159.

    Article  PubMed  CAS  Google Scholar 

  37. Laires MJ, Moreira H, Monteiro CP, et al.: Magnesium, insulin resistance and body composition in healthy postmenopausal women. J Am Coll Nutr 2004, 23:510S-513S.

    PubMed  CAS  Google Scholar 

  38. Huerta MG, Roemmich JN, Kington ML, et al.: Magnesium deficiency is associated with insulin resistance in obese children. Diabetes Care 2005, 28:1175–1181.

    Article  PubMed  CAS  Google Scholar 

  39. Rodiguez-Moran M, Guerrero-Romero F: Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects. Diabetes Care 2003, 26:1147–1152.

    Article  Google Scholar 

  40. Kris-Etherton PM, Yu-Poth S, Sabate J, et al.: Nuts and their bioactive constituents: effects on serum lipids and other factors that affect disease risk. Am J Clin Nutr 1999, 70(suppl):504S-511S.

    PubMed  CAS  Google Scholar 

  41. Jenkins DJA, Kendall CWC, Marchie A, et al.: Type 2 diabetes and the vegetarian diet. Am J Clin Nutr 2003, 78(suppl):610S-616S.

    Google Scholar 

  42. Anderson JW: High carbohydrate, high fiber diets for patients with diabetes. Adv Exp Med Biol 1979, 119:263–273.

    PubMed  CAS  Google Scholar 

  43. Barnard RJ, Massey MR, Cherny S, et al.: Long-term use of high-complex-carbohydrate, high-fiber, low-fat diet and exercise in the treatment of NIDDM patients. Diabetes Care 1983, 6:268–273.

    Article  PubMed  CAS  Google Scholar 

  44. Kurowski EM, Carroll KK: Hypercholesterolemic responses in rabbits to selected groups of dietary essential amino acids. J Nutr 1994,124:185–191.

    Google Scholar 

  45. Wells BJ, Mainous AG, Everett CJ: Association between dietary arginine and C-reactive protein. Nutrition 2005, 21:125–130.

    Article  PubMed  CAS  Google Scholar 

  46. Meydani M: Vitamin E modulation of cardiovascular disease. Ann N Y Acad Sci 2004, 1031:271–279.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Bastyr University, School of Nutrition and Exercise Science, 14500 Juanita Drive N.E, 98028, Kenmore, WA, USA

    Jennifer C. Lovejoy PhD

Authors
  1. Jennifer C. Lovejoy PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lovejoy, J.C. The impact of nuts on diabetes and diabetes risk. Curr Diab Rep 5, 379–384 (2005). https://doi.org/10.1007/s11892-005-0097-x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-005-0097-x

Keywords

Search

Navigation